Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 10-Q Quarterly report for the period ending Wednesday, September 30, 2020

Acro Biomedical Co., Ltd.

HISTORY TOOLS
CIK: 1622996 Ticker: ACBM
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2020
Nov. 13, 2020
Document And Entity Information [Abstract]  
Entity Registrant NameACRO BIOMEDICAL CO., LTD. 
Entity Central Index Key0001622996 
Entity Current Reporting StatusNo 
Current Fiscal Year End Date--12-31 
Entity Filer CategoryNon-accelerated Filer 
Entity Common Stock, Shares Outstanding 47,760,000
Document Type10-Q 
Document Period End DateSep. 30, 2020 
Amendment Flagfalse 
Document Fiscal Year Focus2020 
Document Fiscal Period FocusQ3 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools